Checkpoint Trends Ltd

Checkpoint Trends Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 04 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 January 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Checkpoint Trends Ltd, a key player in the Pharmaceuticals & Biotechnology sector, reached a significant milestone on 7 Jan 2026 by hitting a new 52-week and all-time high of Rs.144.4. This achievement marks a continuation of the stock’s robust momentum, reflecting strong market performance over the past year.

Checkpoint Trends Ltd, a key player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high of Rs.144.4 on 7 January 2026, reflecting a sustained period of robust gains and strong market performance.

Checkpoint Trends Ltd, a key player in the Pharmaceuticals & Biotechnology sector, reached a significant milestone on 6 Jan 2026 by hitting a new 52-week and all-time high of Rs.138.75. This marks a remarkable surge in the stock’s value, reflecting strong momentum over the past several weeks.

Checkpoint Trends Ltd, a key player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high of Rs.138.75 on 6 Jan 2026, marking a significant milestone in its market journey. The stock’s robust performance over recent months has propelled it well above its previous benchmarks, reflecting sustained investor confidence and strong market momentum.

Checkpoint Trends Ltd, a key player in the Pharmaceuticals & Biotechnology sector, reached a significant milestone on 5 Jan 2026 by hitting a new 52-week and all-time high of Rs.132.15. This achievement marks a continuation of the stock’s robust momentum, reflecting a remarkable rally over recent weeks.

Checkpoint Trends Ltd, a key player in the Pharmaceuticals & Biotechnology sector, reached a significant milestone today by hitting an all-time high of Rs.132.15. This achievement marks a continuation of the stock’s robust upward trajectory, reflecting sustained strong performance over recent months and years.

Checkpoint Trends Ltd, a key player in the Pharmaceuticals & Biotechnology sector, reached a significant milestone on 2 Jan 2026 by hitting a new 52-week and all-time high of Rs.125.9, marking a notable surge in its stock price and reflecting strong momentum in recent trading sessions.

Checkpoint Trends Ltd, a key player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high of Rs.125.9 on 2 Jan 2026, underscoring a significant milestone in its market journey. This achievement reflects the company’s sustained performance and robust upward momentum over recent periods.

Checkpoint Trends Ltd, a key player in the Pharmaceuticals & Biotechnology sector, reached a significant milestone today as its stock price soared to an all-time high of Rs.119.95. This achievement marks a continuation of the company’s robust performance, reflecting sustained investor confidence and strong market momentum.

Checkpoint Trends Ltd, a key player in the Pharmaceuticals & Biotechnology sector, reached a significant milestone today by hitting a new 52-week and all-time high of Rs.119.95. This achievement marks a continuation of the stock’s robust momentum, reflecting strong market performance and sustained investor confidence.

Checkpoint Trends Ltd, a key player in the Pharmaceuticals & Biotechnology sector, surged to a new 52-week and all-time high of Rs.114.26 on 31 Dec 2025, marking a significant milestone in its market performance and reflecting strong momentum over recent sessions.

Checkpoint Trends Ltd, a key player in the Pharmaceuticals & Biotechnology sector, reached an all-time high of Rs.114.26 on 31 Dec 2025, marking a significant milestone in its market journey. The stock’s robust performance has outpaced sector and benchmark indices, reflecting sustained investor confidence and strong price momentum.

Checkpoint Trends Ltd is rated Hold by MarketsMOJO, with this rating last updated on 04 Sep 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 25 December 2025, providing investors with the latest insights into its performance and outlook.

Checkpoint Trends, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.113.97 today, underscoring a remarkable rally that has captured market attention. This milestone reflects sustained momentum and notable performance over recent weeks.

Checkpoint Trends, a key player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high of Rs.113.97 today, marking a significant milestone in its market journey. The stock’s performance over recent months has demonstrated notable strength relative to broader market indices and sector peers.

Checkpoint Trends, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.111.75 today, reflecting a sustained upward momentum that has captured market attention. This milestone underscores the stock’s remarkable performance over the past year and highlights the factors driving its recent rally.

Checkpoint Trends, a key player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high of Rs.111.75 today, marking a significant milestone in its market journey. The stock’s sustained upward momentum reflects a remarkable performance over multiple time frames, outpacing broader market indices and sector peers.